🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China flag China · Delayed Price · Currency is CNY
2.900
-0.070 (-2.36%)
Nov 20, 2026, 3:04 PM CST

SHE:300026 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
3,8664,9085,7576,0256,6037,656
Other Revenue
32.7332.7326.2484.3147.4414.63
3,8994,9415,7836,1096,6507,671
Revenue Growth
-28.99%-14.55%-5.34%-8.14%-13.30%18.22%
Cost of Revenue
1,5512,1942,7932,8272,8263,267
Gross Profit
2,3482,7472,9893,2823,8244,403
Selling, General & Admin
1,9832,2822,5342,4632,7513,054
Research & Development
183.39192.26223.45209.81230.85196.59
Other Operating Expenses
62.7953.0548.7441.461.7276.44
Operating Expenses
2,2262,5692,8872,7673,1003,401
Operating Income
121.64177.81102.42515.52724.421,002
Interest Expense
-13.78-19.33-44.86-61.57-69.67-50.1
Interest & Investment Income
11.6910.8417.3119.3114.1811.38
Currency Exchange Gain (Loss)
-2.74-2.743.922.4117.62-6.34
Other Non Operating Income (Expenses)
-19.22-35.84-22.2-18.49-35.65-26.86
EBT Excluding Unusual Items
97.58130.7356.59457.19650.91930.58
Impairment of Goodwill
-39.6-39.6-17.34-23.52--58.18
Gain (Loss) on Sale of Investments
-11.18-3.66-5.63-1.4--22.98
Gain (Loss) on Sale of Assets
0.770.71.081.060.01-2.87
Asset Writedown
14.64-4.98-30.33-4.05-2.36-9.35
Other Unusual Items
4.05-0.5549.62177.5467.8216.99
Pretax Income
66.2782.6553.98606.82716.37854.18
Income Tax Expense
41.7560.4231.04105.2595.14183.32
Earnings From Continuing Operations
24.5222.2222.95501.57621.23670.85
Minority Interest in Earnings
1.25-3.73-1.485.063.0116.47
Net Income
25.7718.521.47506.63624.24687.32
Net Income to Common
25.7718.521.47506.63624.24687.32
Net Income Growth
--13.84%-95.76%-18.84%-9.18%19.87%
Shares Outstanding (Basic)
2,0311,8502,1472,9802,9732,988
Shares Outstanding (Diluted)
2,0311,8502,1472,9802,9732,988
Shares Change
-1.45%-13.84%-27.97%0.26%-0.53%-0.98%
EPS (Basic)
0.010.010.010.170.210.23
EPS (Diluted)
0.010.010.010.170.210.23
EPS Growth
-0%-94.12%-19.05%-8.70%21.05%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
659.42681.09659.121,183-24.93-285.85
Free Cash Flow Per Share
0.330.370.310.40-0.01-0.10
Dividend Per Share
0.0100.0100.0300.0300.0300.040
Dividend Growth
-66.67%-66.67%0%0%-25.00%0%
Gross Margin
60.22%55.59%51.69%53.73%57.50%57.40%
Operating Margin
3.12%3.60%1.77%8.44%10.89%13.07%
Profit Margin
0.66%0.37%0.37%8.29%9.39%8.96%
Free Cash Flow Margin
16.91%13.78%11.40%19.36%-0.38%-3.73%
EBITDA
377.42450.9398.59807.69974.091,217
EBITDA Margin
9.68%9.13%6.89%13.22%14.65%15.86%
D&A For EBITDA
255.78273.09296.18292.17249.67214.2
EBIT
121.64177.81102.42515.52724.421,002
EBIT Margin
3.12%3.60%1.77%8.44%10.89%13.07%
Effective Tax Rate
62.99%73.11%57.49%17.34%13.28%21.46%
Revenue as Reported
3,8994,9415,7836,1096,6507,671
Advertising Expenses
-13.378.69.1512.621.21